NI
LLY icon

NCP Inc’s Eli Lilly LLY Stock Holding History

NCP Inc’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,200
Closed -$11M – 122
2025
Q4 		$11M Buy
10,200
+3,200
+46% +$3.06M 8.84% 2
2025
Q3 		$5.34M Hold
7,000
– – 3.97% 9
2025
Q2 		$5.46M Buy
7,000
+6,000
+600% +$4.66M 5.14% 6
2025
Q1 		$826K Sell
1,000
-1,000
-50% -$832K 1.11% 25
2024
Q4 		$1.54M Hold
2,000
– – 0.79% 19
2024
Q3 		$1.77M Buy
+2,000
New +$1.8M 1.01% 14

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

NCP Inc's LLY Position: Q1 2026 in Review

NCP Inc sold out of Eli Lilly (LLY) in Q1 2026, closing a stake of 10,200 shares — an estimated $11M sold.

NCP Inc first reported a position in LLY in Q3 2024 and held it in 6 quarters. The position peaked at $11M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • NCP Inc reported no remaining Eli Lilly position as of Q1 2026 after selling out during the quarter.
  • NCP Inc sold 10,200 Eli Lilly shares in Q1 2026, an estimated $11M.
  • NCP Inc first reported a position in Eli Lilly in Q3 2024 and held it in 6 quarters.
  • NCP Inc's Eli Lilly position peaked at $11M in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on NCP Inc's 13F filing for Q1 2026, filed 8 May 2026.